p53 and PTEN regulate TAGLN to inhibit bladder cancer cell proliferation.[12] As a result, we now broaden the molecular interactome with TAGLN to add HDAC2 regulating p53 deacetylation at K382, in turn, mediating acceleration of cell cycle progression. This evidence concerns the gene HDAC2 and urinary bladder carcinoma.